Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RU-486 for Adenomyosis-Related Pain
ChiCTR-IPR-16007815Phase 4Recruiting
- Sponsor
- Women's Hospital, School of Medicine, Zhejiang University
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mifepristone in adenomyosis and endometriosis (3 arms), sponsored by Women's Hospital, School of Medicine, Zhejiang University. Primary endpoints: Pain, Hypermenorrhea and 5 more. Started Jan 2015; status: recruiting.
02
Drugs
mifepristone
03
Conditions
adenomyosisendometriosis
Beyond the preview
Go deeper on ChiCTR-IPR-16007815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16007815.